SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-23-051400
Filing Date
2023-04-27
Accepted
2023-04-27 16:30:33
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2313721d1_10ka.htm   iXBRL 10-K/A 270647
2 EXHIBIT 31.3 tm2313721d1_ex31-3.htm EX-31.3 3965
3 EXHIBIT 31.4 tm2313721d1_ex31-4.htm EX-31.4 3335
  Complete submission text file 0001104659-23-051400.txt   521589

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pmn-20221231.xsd EX-101.SCH 3063
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmn-20221231_lab.xml EX-101.LAB 36509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmn-20221231_pre.xml EX-101.PRE 24019
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2313721d1_10ka_htm.xml XML 5640
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41429 | Film No.: 23857573
SIC: 2834 Pharmaceutical Preparations